This site is intended for healthcare professionals
Login
Register
Medical Education
Specialty
Drugs
News
Congress
Search
Menu
Medical Education
Specialty
Drugs
News
Congress
Home
/
Medical Education
/
Antiplatelet therapy in ACS: Choices and Controver...
/
Videos
/
Should another prospective randomised trial be per...
Should another prospective randomised trial be performed for ticagrelor versus prasugrel?
Antiplatelet therapy in ACS
ACS Patient Focus
Expert Opinion
ESC 2022 Highlights
Bookmark
Bookmarked
previous video
Roundtable Discussion: Closing remarks
next video
Controversies on choice of P2Y12 inhibitor: Are the recommendations justifiable?
Top
